DK0981330T3 - Topiske præparater - Google Patents

Topiske præparater

Info

Publication number
DK0981330T3
DK0981330T3 DK98923030T DK98923030T DK0981330T3 DK 0981330 T3 DK0981330 T3 DK 0981330T3 DK 98923030 T DK98923030 T DK 98923030T DK 98923030 T DK98923030 T DK 98923030T DK 0981330 T3 DK0981330 T3 DK 0981330T3
Authority
DK
Denmark
Prior art keywords
pharmaceutically acceptable
eutectic mixture
topical composition
topical preparations
continuous phase
Prior art date
Application number
DK98923030T
Other languages
English (en)
Inventor
Clare Passmore
Claire Gilligan
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Application granted granted Critical
Publication of DK0981330T3 publication Critical patent/DK0981330T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DK98923030T 1997-05-14 1998-05-14 Topiske præparater DK0981330T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE970346 1997-05-14
PCT/IE1998/000036 WO1998051283A1 (en) 1997-05-14 1998-05-14 Topical compositions

Publications (1)

Publication Number Publication Date
DK0981330T3 true DK0981330T3 (da) 2002-12-02

Family

ID=11041469

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98923030T DK0981330T3 (da) 1997-05-14 1998-05-14 Topiske præparater

Country Status (15)

Country Link
US (1) US6841161B1 (da)
EP (1) EP0981330B1 (da)
JP (1) JP2001525820A (da)
CN (1) CN1255850A (da)
AT (1) ATE221770T1 (da)
AU (1) AU734429B2 (da)
CA (1) CA2289966A1 (da)
DE (1) DE69807065T2 (da)
DK (1) DK0981330T3 (da)
ES (1) ES2182309T3 (da)
IL (1) IL132682A (da)
NO (1) NO995573L (da)
NZ (1) NZ501235A (da)
PT (1) PT981330E (da)
WO (1) WO1998051283A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6299902B1 (en) 1999-05-19 2001-10-09 The University Of Georgia Research Foundation, Inc. Enhanced transdermal anesthesia of local anesthetic agents
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
EP1406633B1 (en) 2001-06-18 2011-10-05 Noven Pharmaceuticals, Inc. Enhanced drug delivery in transdermal systems
US6528076B2 (en) * 2001-07-06 2003-03-04 Magic Herb Corp. Topical compositions and methods for treating pain
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20060241175A1 (en) * 2002-09-27 2006-10-26 Joseph Schwarz Vehicle for topical delivery of anti-inflammatory compounds
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
US8637503B2 (en) * 2003-05-16 2014-01-28 Board Of Regents, The University Of Texas System Phenothiazine enantiomers as agents for the prevention of bone loss
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
DE102004001093A1 (de) * 2004-01-05 2005-07-28 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer synergistischen topischen Therapie neuromuskulärer Schmerzen
JP5148271B2 (ja) * 2004-06-02 2013-02-20 ニューロジズエックス，インコーポレーテッド 疼痛処置のためのカプサイシノイド、局所麻酔薬および／または鎮痒薬を含有する処方物
US20070048360A1 (en) * 2005-08-23 2007-03-01 R Carrara Dario N Pharmaceutical compositions with melting point depressant agents and method of making same
JP5713534B2 (ja) * 2005-10-07 2015-05-07 ザ ユニバーシティ オブ アラバマ 多機能イオン性液体組成物
US20070224261A1 (en) * 2006-03-22 2007-09-27 Peter Draper Eutectic liquid drug formulation
US20080255103A1 (en) * 2007-04-12 2008-10-16 Ballay Pharmaceuticals, Inc. Antihistamine and anti-nausea pharmaceutical compositions for topical application
BRPI0819028B1 (pt) 2007-12-06 2016-09-20 Unilever Nv composição de cuidados dos cabelos/couro cabeludo e uso de uma composição
CA2707546A1 (en) 2007-12-06 2009-06-11 Unilever Plc Personal care composition
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
AU2010336441B2 (en) 2009-12-23 2015-02-05 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
KR20120118495A (ko) * 2010-04-21 2012-10-26 테이코쿠 팔마 유에스에이, 인코포레이티드 국부 마취제 에멀전 조성물 및 이의 제조 및 사용 방법
US20130261142A1 (en) * 2010-12-15 2013-10-03 Hung-Cheng Lai Compounds used for treating cancer and the use thereof
GB201113662D0 (en) * 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
WO2014123100A1 (ja) * 2013-02-05 2014-08-14 リンテック株式会社 貼付型表面麻酔剤
CN104548070B (zh) * 2015-01-19 2016-08-24 常州亚当生物技术有限公司 复方辣椒碱乳剂在治疗皮肤创伤的应用
GB202103567D0 (en) * 2021-03-15 2021-04-28 Queens Univ Of Belfast Sutures
CN116549421A (zh) * 2022-01-27 2023-08-08 北京泰德制药股份有限公司 一种复方透皮贴剂及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206021A (en) 1988-05-09 1993-04-27 Rhone-Poulenc Ag Company Stabilized oil-in-water emulsions or suspoemulsions containing pesticidal substances in both oil and water phases
GB8921710D0 (en) * 1989-09-26 1989-11-08 Mentholatum Co Ltd Ibuprofen triturates and topical compositions containing same
WO1991008670A1 (en) * 1989-12-11 1991-06-27 Vincent Henry Guerrini Pesticidal composition comprising azadirachtin, dialkyltoluamide and oil (geraniol and/or citronellal)
US5525597A (en) * 1993-12-14 1996-06-11 Kalamazoo Holdings, Inc. Synergistic insecticidal compositions comprising capsicum and insecticidal use thereof
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
US6251405B1 (en) * 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
US5658583A (en) 1995-07-28 1997-08-19 Zhang; Jie Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals

Also Published As

Publication number Publication date
NO995573D0 (no) 1999-11-12
ATE221770T1 (de) 2002-08-15
IL132682A0 (en) 2001-03-19
PT981330E (pt) 2002-12-31
DE69807065D1 (de) 2002-09-12
EP0981330A1 (en) 2000-03-01
JP2001525820A (ja) 2001-12-11
IL132682A (en) 2004-06-20
EP0981330B1 (en) 2002-08-07
CA2289966A1 (en) 1998-11-19
WO1998051283A1 (en) 1998-11-19
DE69807065T2 (de) 2003-05-08
US6841161B1 (en) 2005-01-11
AU7545698A (en) 1998-12-08
NO995573L (no) 2000-01-14
AU734429B2 (en) 2001-06-14
ES2182309T3 (es) 2003-03-01
NZ501235A (en) 2001-06-29
CN1255850A (zh) 2000-06-07

Similar Documents

Publication Publication Date Title
NO995573L (no) Topiske preparater
ITMI961152A0 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
BG106030A (en) Pharmaceutical composition
HUP9701560A1 (hu) "Olaj a vízben"típusú topikális alkalmazású folyékony emulzió készítmény
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
NO20002800L (no) Cyklosporinholdig mikroemulsjon, for konsentratsammensetning
EP0993831A3 (en) Compounds and compositions for delivering active agents
PL335575A1 (en) Hydrophilic two-component systems for use in administration of cyclosporine
FI973518A7 (fi) Piperidinoalkanoliyhdistettä tai sen farmaseuttisesti hyväksyttävää suolaa sisltävä farmaseuttinen koostumus kiinteässä yksikköannosmuodossa
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
ATE270557T1 (de) Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen
DE69836424D1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
CA2338358A1 (en) Compounds and compositions for delivering active agents
AU2962295A (en) Cannabinoid receptor antagonists
FR2766706B1 (fr) Complexes particulaires stables de charge globale neutre ou negative de structure multilamellaire composes par au moins une substance biologiquement active globalement anionique et un constituant cationique, leur preparation et utilisation
EE200000388A (et) Ravimkoostis, mis sisaldab mitselle, mis sisaldavad lipofiilset glükokortikosteroidi ja ainult üht pindaktiivset ainet
DK1126867T3 (da) Sammensætning til forebyggelse og/eller behandling af åreforkalkning
BR9709062A (pt) Composto, composição farmacêutica, e, uso de um composto.
PT918774E (pt) Compostos moduladores do receptor para androgenio e metodos
TR199801268T2 (xx) Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler.
PT1071433E (pt) 2',2'-difluoronuecleosidos para terapia imunossupressora e preparados farmaceuticos combinados
CA2270177A1 (en) Transdermal administration of ment
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
NZ319138A (en) Composition containing cytochrome complex III and fenazaquin for combatting parasitic fungi
ES2171018T3 (es) Uso de agentes inmunomoduladores.